Opportunity Information: Apply for PAR 16 446
The NIAMS Clinical Trial Planning Grant (R34) is a discretionary NIH grant opportunity (Funding Opportunity Number PAR 16-446; CFDA 93.846) offered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Its purpose is to fund the upfront planning work needed before launching an investigator-initiated clinical interventional trial. Rather than paying for the full execution of a clinical trial, this mechanism supports the practical and regulatory groundwork that turns a promising clinical concept into a well-designed, feasible, and implementation-ready study.
This R34 is specifically aimed at helping investigators complete the essential planning, design, and documentation steps that typically must be in place before a trial can responsibly begin. In practice, this kind of planning can include finalizing the protocol and statistical analysis plan, confirming feasibility and recruitment strategies, developing detailed study procedures and manuals of operations, setting up data management and quality control plans, preparing safety monitoring approaches, and assembling the required trial documentation. The announcement emphasizes that the planned trial should be hypothesis-driven, built around clear milestones, and positioned to deliver high-impact results that align with the NIAMS research mission (which broadly covers arthritis and rheumatic diseases, musculoskeletal disorders, and skin diseases).
A key point in the structure of this opportunity is that the R34 is meant to be a preparatory step before seeking a larger implementation award. NIAMS notes that successful completion of the agreed-upon R34 milestones is recommended prior to submitting a U01 clinical trial implementation application, which would support actually running the study. In other words, the R34 functions like a bridge between early trial concept development and full clinical trial conduct, with the expectation that the planning period will produce a trial package that is ready to move forward without major redesign.
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities. Eligible applicants listed include state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations other than small businesses; and small businesses. The FOA also explicitly calls out additional eligible applicant categories such as Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; regional organizations; eligible federal agencies; and U.S. territories or possessions. At the same time, it draws a firm boundary around foreign participation: non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply. However, foreign components, as defined in the NIH Grants Policy Statement, are allowed, meaning limited international involvement may be permissible when structured as a foreign component within an eligible U.S. applicant organization and justified under NIH policy.
From an administrative standpoint, the opportunity is categorized under Health as the funding activity area and uses the grant funding instrument. The source data notes an original closing date of 2020-01-14 and a creation date of 2016-09-23. The award ceiling and expected number of awards are not specified in the provided listing, which typically means applicants would need to consult the full FOA text or NIAMS/NIH guidance for budget limits, project period expectations, and any institute-specific constraints.
Overall, this R34 is best understood as targeted support for the often time-consuming and highly detailed pre-implementation phase of investigator-initiated clinical trials. It is designed for teams that have a strong clinical question and a plausible intervention plan, but who need dedicated resources to complete rigorous trial planning, lock down milestone-based readiness criteria, and assemble the full set of materials needed to compete for and successfully launch a subsequent NIAMS-supported implementation award such as a U01.Apply for PAR 16 446
- The National Institutes of Health in the health sector is offering a public funding opportunity titled "NIAMS Clinical Trial Planning Grant (R34)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.846.
- This funding opportunity was created on 2016-09-23.
- Applicants must submit their applications by 2020-01-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Eligible applicants include: State governments, County governments, City or township governments, Special district governments, Independent school districts, Public and State controlled institutions of higher education, Native American tribal governments (Federally recognized), Public housing authorities/Indian housing authorities, Native American tribal organizations (other than Federally recognized tribal governments), Nonprofits having a 501 (c) (3) status with the IRS, other than institutions of higher education, Nonprofits that do not have a 501 (c) (3) status with the IRS, other than institutions of higher education, Private institutions of higher education, For-profit organizations other than small businesses, Small businesses, Others.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs): NIAMS Clinical Trial Planning Grant (R34)
What is the NIAMS Clinical Trial Planning Grant (R34)?
The NIAMS Clinical Trial Planning Grant (R34) is a discretionary NIH grant opportunity offered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). It supports the upfront planning work required before launching an investigator-initiated clinical interventional trial, rather than paying for the full execution of the trial.
What is the purpose of this R34 opportunity?
The purpose is to fund practical and regulatory groundwork that turns a clinical concept into a well-designed, feasible, and implementation-ready clinical trial. The focus is on planning, design, and documentation steps needed before a trial can responsibly begin.
Does this grant pay for running the clinical trial?
No. This mechanism is intended for clinical trial planning and preparation, not for full clinical trial conduct or execution.
What kinds of activities can the R34 support during the planning phase?
Examples of supported planning activities described include finalizing the protocol and statistical analysis plan, confirming feasibility and recruitment strategies, developing detailed study procedures and manuals of operations, setting up data management and quality control plans, preparing safety monitoring approaches, and assembling required trial documentation.
What is meant by "investigator-initiated clinical interventional trial" in this context?
Based on the provided description, this opportunity is aimed at trials initiated by investigators (rather than being fully directed by the sponsor) and focused on an intervention, with the R34 supporting the steps needed to prepare that interventional study for implementation.
What characteristics should the planned trial have?
The planned trial should be hypothesis-driven, built around clear milestones, and positioned to deliver high-impact results aligned with the NIAMS research mission.
What is the NIAMS research mission area referenced for alignment?
The NIAMS mission is described broadly as covering arthritis and rheumatic diseases, musculoskeletal disorders, and skin diseases.
How do milestones factor into this R34 program?
The announcement emphasizes milestone-based planning. The expectation is that the R34 period results in agreed-upon milestones and readiness criteria being met, producing a trial package that is ready to move forward without major redesign.
How is the R34 intended to relate to a later implementation award?
The R34 is positioned as a preparatory step before seeking a larger implementation award. NIAMS notes that successful completion of the agreed-upon R34 milestones is recommended prior to submitting a U01 clinical trial implementation application, which would support actually running the study.
What is a U01 in relation to this R34?
In the context provided, a U01 is referenced as a clinical trial implementation application mechanism that may be pursued after completing R34 milestones, and it would support conducting the study.
Who is eligible to apply?
Eligibility is broad and includes many types of U.S.-based organizations and governmental entities, including state, county, city or township governments; special district governments; independent school districts; public and state-controlled institutions of higher education; private institutions of higher education; federally recognized Native American tribal governments; tribal organizations other than federally recognized tribal governments; public housing authorities/Indian housing authorities; nonprofits with or without 501(c)(3) status (outside higher education); for-profit organizations other than small businesses; and small businesses.
Are there additional specifically named eligible applicant categories?
Yes. The FOA explicitly calls out Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISIs); Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Tribally Controlled Colleges and Universities (TCCUs); faith-based or community-based organizations; regional organizations; eligible federal agencies; and U.S. territories or possessions.
Are non-U.S. (foreign) organizations eligible to apply?
No. Non-domestic (non-U.S.) entities and non-domestic components of U.S. organizations are not eligible to apply.
Is any international involvement allowed at all?
Yes, limited international involvement may be permissible through foreign components as defined in the NIH Grants Policy Statement, when structured as a foreign component within an eligible U.S. applicant organization and justified under NIH policy.
What is the funding agency and institute for this opportunity?
This is an NIH funding opportunity offered by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS).
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number provided is PAR 16-446.
What is the CFDA number listed for this opportunity?
The CFDA number provided is 93.846.
What is the funding instrument and activity area?
The opportunity uses the grant funding instrument and is categorized under Health as the funding activity area.
What is the original closing date shown in the listing?
The source data notes an original closing date of 2020-01-14.
What is the creation date shown for the opportunity?
The listing notes a creation date of 2016-09-23.
Is there an award ceiling or an expected number of awards listed?
No. The award ceiling and expected number of awards are not specified in the provided listing.
Where would an applicant normally look for budget limits or project period expectations?
Because the provided listing does not include those details, applicants would typically need to consult the full FOA text or NIAMS/NIH guidance for budget limits, project period expectations, and any institute-specific constraints.
What is the main outcome NIAMS seems to expect by the end of the R34 planning period?
The R34 is intended to produce a complete, well-documented, milestone-driven trial plan (a "trial package") that is ready to move forward to an implementation application and launch without major redesign.
What stage of readiness is this R34 best suited for?
It is best suited for teams that have a strong clinical question and a plausible intervention plan, but still need resources to complete rigorous pre-implementation planning, confirm feasibility, finalize design details, and prepare the documentation needed to responsibly begin the trial and compete for an implementation award.
Browse more opportunities from the same category: Health
Next opportunity: Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01)
Previous opportunity: RESTORE Act Centers of Excellence Research Grants Program
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for PAR 16 446
Applicants also applied for:
Applicants who have applied for this opportunity (PAR 16 446) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIH-CASIS Coordinated Microphysiological Systems Program for Translational Research in Space (UG3/UH3) Apply for RFA TR 16 019 Funding Number: RFA TR 16 019 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| International Bioethics Research Training Program (D43) Apply for PAR 16 454 Funding Number: PAR 16 454 Agency: National Institutes of Health Category: Health Funding Amount: $230,000 |
| Building Sustainable Capacity of the Ministry of Home Affairs to Address HIV and TB Prevention, Care and Treatment in Zambian Prisons and Respond to Child Sexual Abuse and Sexual Gender-Based Violence in the Republic of Zambia under the President’s Apply for CDC RFA GH15 160103CONT17 Funding Number: CDC RFA GH15 160103CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32) Apply for PAR 16 458 Funding Number: PAR 16 458 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Expanding and Strengthening Family Planning Service Options in Uganda Apply for AID 617 PD 16 0001 Funding Number: AID 617 PD 16 0001 Agency: Uganda USAID-Kampala Category: Health Funding Amount: $35,000,000 |
| Partnerships for Development of Vaccines to Prevent Mycobacterium tuberculosis Infection and/or Tuberculosis Disease (R01) Apply for RFA AI 16 079 Funding Number: RFA AI 16 079 Agency: National Institutes of Health Category: Health Funding Amount: $1,050,000 |
| Secondary Analyses of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21) Apply for PAR 17 004 Funding Number: PAR 17 004 Agency: National Institutes of Health Category: Health Funding Amount: $75,000 |
| Animal and Biological Material Resource Centers (P40) Apply for PAR 17 006 Funding Number: PAR 17 006 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Center of Excellence for Comprehensive Integrated HIV Care and Treatment Services in Lilongwe, Malawi Apply for CDC RFA GH12 124905CONT17 Funding Number: CDC RFA GH12 124905CONT17 Agency: Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Large Health Services Research Demonstration and Dissemination Projects for Prevention of Healthcare-Associated Infections (R18) Apply for PA 17 007 Funding Number: PA 17 007 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| Large Research Projects for Prevention of Healthcare-Associated Infections (R01) Apply for PA 17 008 Funding Number: PA 17 008 Agency: Agency for Health Care Research and Quality Category: Health Funding Amount: Case Dependent |
| DRAFT Ending AIDS in West Africa Apply for RFI 624 17 EAWA Funding Number: RFI 624 17 EAWA Agency: West Africa USAID-Ghana Category: Health Funding Amount: $16,000,000 |
| Broad Agency Announcement (BAA) for Advancing Universal Health Coverage (UHC) in Bangladesh Apply for BAA 388 17 000002 Funding Number: BAA 388 17 000002 Agency: Bangladesh USAID-Dhaka Category: Health Funding Amount: $90,000,000 |
| Implementation Science Research to Improve Dental, Oral and Craniofacial Health (U01) Apply for RFA DE 18 001 Funding Number: RFA DE 18 001 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Stimulating Peripheral Activity to Relieve Conditions (SPARC): Pre-clinical Development of Existing Market-approved Devices to Support New Market Indications (U18) Apply for RFA RM 16 027 Funding Number: RFA RM 16 027 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R41/R42) Apply for PAS 17 023 Funding Number: PAS 17 023 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| RFI - Multi-Sectoral Nutrition Activity Apply for RFI OAA 16 MSNA Funding Number: RFI OAA 16 MSNA Agency: Agency for International Development Category: Health Funding Amount: Case Dependent |
| Role of Peripheral Proteostasis on Brain Aging and on Alzheimers Disease (R01) Apply for RFA AG 17 050 Funding Number: RFA AG 17 050 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Revision Requests for Active Alzheimer's Disease Research Centers (P50) Apply for PAR 17 020 Funding Number: PAR 17 020 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Development and/or Validation of Devices or Electronic Systems to Monitor or Enhance Mind and Body Interventions (R43/R44) Apply for PAS 17 022 Funding Number: PAS 17 022 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "PAR 16 446", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.